579 related items for PubMed ID: 12568207
1. Effects of angiotensin converting enzyme inhibitor on renal function in patients of membranoproliferative glomerulonephritis with mild to moderate renal insufficiency.
Giri S, Mahajan SK, Sen R, Sharma A.
J Assoc Physicians India; 2002 Oct; 50():1245-9. PubMed ID: 12568207
[Abstract] [Full Text] [Related]
2. Blood pressure reduction associated with preservation of renal function in hypertensive patients with IgA nephropathy: a 3-year follow-up.
Kanno Y, Okada H, Saruta T, Suzuki H.
Clin Nephrol; 2000 Nov; 54(5):360-5. PubMed ID: 11105796
[Abstract] [Full Text] [Related]
3. [Kidney function in hypertensive patients with chronic renal failure treated with the dual eliminated ACE-inhibitor spirapril].
Haufe CC, Sierakowski B, Jansa U, Stein G.
Med Klin (Munich); 1994 Aug 15; 89(8):416-20. PubMed ID: 7968874
[Abstract] [Full Text] [Related]
4. Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients.
Chan JC, Ko GT, Leung DH, Cheung RC, Cheung MY, So WY, Swaminathan R, Nicholls MG, Critchley JA, Cockram CS.
Kidney Int; 2000 Feb 15; 57(2):590-600. PubMed ID: 10652036
[Abstract] [Full Text] [Related]
5. [Spirapril - a new long-acting ACE inhibitor: efficacy and safety in patients with arterial hypertension in combination with diabetes mellitus and impaired kidney function].
Iakusevich VV, Mozheĭko ME, Paliutin ShKh, Berezina MIu, Martsevich SIu, Shal'nova SA, Deev AD, Kutishenko NP, Alimova EV, Koniakhina IP, Semenova IuE.
Ter Arkh; 2000 Feb 15; 72(10):82-6. PubMed ID: 11220887
[Abstract] [Full Text] [Related]
6. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
Esnault VL, Brown EA, Apetrei E, Bagon J, Calvo C, DeChatel R, Holdaas H, Krcmery S, Kobalava Z, Amlodipine Versus Enalapril in Renal failure (AVER) Study Group.
Clin Ther; 2008 Mar 15; 30(3):482-98. PubMed ID: 18405787
[Abstract] [Full Text] [Related]
7. Low-dose angiotensin II receptor antagonists and angiotensin II-converting enzyme inhibitors alone or in combination for treatment of primary glomerulonephritis.
Renke M, Tylicki L, Rutkowski P, Rutkowski B.
Scand J Urol Nephrol; 2004 Mar 15; 38(5):427-33. PubMed ID: 15764256
[Abstract] [Full Text] [Related]
8. Angiotensin converting enzyme inhibitor and chronic renal failure.
Sitprija V, Lumlertgul D.
J Med Assoc Thai; 1993 Jul 15; 76(7):359-67. PubMed ID: 8089635
[Abstract] [Full Text] [Related]
9. Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency.
Bailey RR, Shand BI, Smith AH, Robson RA, Lynn KL.
Clin Nephrol; 1997 Oct 15; 48(4):224-9. PubMed ID: 9352156
[Abstract] [Full Text] [Related]
10. Renal effects of amlodipine.
Saruta T, Kanno Y, Hayashi K, Suzuki H.
J Hum Hypertens; 1995 Mar 15; 9 Suppl 1():S11-6. PubMed ID: 7783108
[Abstract] [Full Text] [Related]
11. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group.
Maschio G, Alberti D, Janin G, Locatelli F, Mann JF, Motolese M, Ponticelli C, Ritz E, Zucchelli P.
N Engl J Med; 1996 Apr 11; 334(15):939-45. PubMed ID: 8596594
[Abstract] [Full Text] [Related]
12. Efficacy of enalapril in the treatment of steroid resistant idiopathic nephrotic syndrome.
Prasher PK, Varma PP, Baliga KV.
J Assoc Physicians India; 1999 Feb 11; 47(2):180-2. PubMed ID: 10999084
[Abstract] [Full Text] [Related]
13. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR.
Clin Ther; 2007 Sep 11; 29(9):1803-24. PubMed ID: 18035185
[Abstract] [Full Text] [Related]
14. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
Salako BL, Finomo FO, Kadiri S, Arije A, Olatosin AO.
Afr J Med Med Sci; 2002 Mar 11; 31(1):53-7. PubMed ID: 12518931
[Abstract] [Full Text] [Related]
15. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
Petersen LJ, Petersen JR, Talleruphuus U, Møller ML, Ladefoged SD, Mehlsen J, Jensen HA.
Clin Nephrol; 2001 May 11; 55(5):375-83. PubMed ID: 11393383
[Abstract] [Full Text] [Related]
16. Antihypertensive efficacy of angiotensin converting enzyme inhibition and aspirin counteraction.
Guazzi MD, Campodonico J, Celeste F, Guazzi M, Santambrogio G, Rossi M, Trabattoni D, Alimento M.
Clin Pharmacol Ther; 1998 Jan 11; 63(1):79-86. PubMed ID: 9465844
[Abstract] [Full Text] [Related]
17. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
Mugellini A, Dobovisek J, Planinc D, Cremonesi G, Fogari R.
Clin Ther; 2004 Sep 11; 26(9):1419-26. PubMed ID: 15531004
[Abstract] [Full Text] [Related]
18. Comparison of quality of life and cough on eprosartan and enalapril in people with moderate hypertension.
Breeze E, Rake EC, Donoghue MD, Fletcher AE.
J Hum Hypertens; 2001 Dec 11; 15(12):857-62. PubMed ID: 11773988
[Abstract] [Full Text] [Related]
19. [Treatment of mild and moderate hypertension with enalapril (multicenter study of enap and enap N in Ukraine)].
Dziak GV, Kolomiets SN, Minakov AI, Fushteĭ IM, Iavorskiĭ OG, Bekker VF, Vankhanen VN, Davydova IV, Zaĭtseva VI, Kolesnik TV, Kolomiets VV, Svishchenko EP, Taran AI, Shlykova NA, Barbich-Zhagar B.
Ter Arkh; 1999 Dec 11; 71(1):31-4. PubMed ID: 10097297
[Abstract] [Full Text] [Related]
20. The long-term tolerability of enalapril in hypertensive patients with renal impairment.
Keane WF, Polis A, Wolf D, Faison E, Shahinfar S.
Nephrol Dial Transplant; 1997 Dec 11; 12 Suppl 2():75-81. PubMed ID: 9269706
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
